Grants and Contributions:

Title:
COVID-19 Rapid Response: Assessment of the Effect of lung-directed Site-Specific Immunomodulator (SSI) in clinical trial QBKPN-CV-01: Assessment of the Effect of QBKPN Site-Specific Immunomodulator (SSI) on Innate Immunity and COVID-19 Vaccine Immune Response and Maintenance in Adults 65 Years of Age or Older
Agreement Number:
995430
Agreement Value:
$5,426,172.00
Agreement Date:
Sep 1, 2022 - Mar 31, 2024
Description:
This project will support a Phase 2, randomized, placebo-controlled clinical trial designed to test the effectiveness of a lung-directed immunomodulator on immune response, restoration of innate immunity and/or reduction of morbidity and mortality from COVID-19 in a test population of adults 65 years of age or older in long term care or assisted living facilities.
Organization:
National Research Council Canada
Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:
Burnaby, British Columbia, CA V5G 4X4
Reference Number:
172-2022-2023-Q2-995430
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
842333817
Recipient Type:
For-profit organization
Additional Information:

This agreement has been amended 1 time(s). The total amended value is 500,000 dollars.

Amendment Date
Jun 12, 2023
Recipient's Legal Name:
Qu Biologics Inc.
Federal Riding Name:
Burnaby South
Federal Riding Number:
59003
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: